SEC Form D filing

Aminex Therapeutics, Inc., 2025-12-05

An SEC Form D private-offering notice from Kenmore, WA, a $30,000,030 filer-stated offering target in Biotech. Filed 2025-12-05. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Aminex Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage immuno-oncology company developing AMXT 1501 plus DFMO, an oral polyamine-depletion combination therapy for cancer.

Filed 2025-12-05Filed to raise $30,000,030First money in 2022-10-25Raised so far $15,084,670HQ (as filed) Kenmore, WASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified aminextx.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in Washington →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source